US Stock MarketDetailed Quotes

Alto Neuroscience (ANRO)

Watchlist
  • 17.180
  • -0.410-2.33%
Close Jan 22 16:00 ET
  • 17.180
  • 0.0000.00%
Post 20:01 ET
533.72MMarket Cap-7.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alto Neuroscience (ANRO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.42%-9.92M
-17.83%-13.78M
-50.74%-16.56M
-41.78%-47.42M
-12.99%-13.02M
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
-64.01%-33.45M
-91.40%-11.52M
Net income from continuing operations
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
-31.02%-36.31M
-46.59%-11.22M
Operating gains losses
2,750.00%114K
-94.44%1K
197.12%722K
-62.86%52K
-93.74%30K
101.77%4K
117.65%18K
2,309.09%243K
-62.06%140K
280.75%479K
Depreciation and amortization
34.43%164K
49.56%169K
76.29%171K
34.58%502K
51.79%170K
93.65%122K
0.89%113K
12.79%97K
9.06%373K
15.46%112K
Other non cash items
239.46%499K
-48.48%457K
-0.48%411K
1,066.89%1.76M
190.52%315K
-10.37%147K
461.39%887K
133.33%413K
-42.59%151K
-970.00%-348K
Change In working capital
-53.45%1.3M
-9.44%1.3M
-1,727.06%-4.66M
681.66%4.06M
108.56%99K
234.05%2.79M
138.33%1.43M
73.87%-255K
-115.24%-698K
-241.32%-1.16M
-Change in receivables
----
----
----
----
----
--0
--0
121.62%8K
----
----
-Change in prepaid assets
-15.59%628K
310.48%509K
5.00%-1.69M
-259.11%-463K
0.00%450K
1,007.32%744K
-67.96%124K
-283.84%-1.78M
593.22%291K
259.01%450K
-Change in payables and accrued expense
-67.24%669K
-39.82%786K
-294.43%-2.97M
557.33%4.52M
72.60%-351K
228.82%2.04M
794.52%1.31M
421.26%1.53M
-128.42%-989K
-1,742.31%-1.28M
Cash from discontinued investing activities
Operating cash flow
15.42%-9.92M
-17.83%-13.78M
-50.74%-16.56M
-41.78%-47.42M
-12.99%-13.02M
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
-64.01%-33.45M
-91.40%-11.52M
Investing cash flow
Cash flow from continuing investing activities
0
0
89.29%-24K
-341.49%-2.08M
-43.75%-506K
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
35.79%-470K
-467.74%-352K
Capital expenditure reported
--0
--0
89.29%-24K
-341.49%-2.08M
-43.75%-506K
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
35.79%-470K
-467.74%-352K
Cash from discontinued investing activities
Investing cash flow
--0
--0
89.29%-24K
-341.49%-2.08M
-43.75%-506K
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
35.79%-470K
-467.74%-352K
Financing cash flow
Cash flow from continuing financing activities
-88.38%153K
361.97%613K
-93.22%9.13M
99.16%135.69M
-99.89%49K
2,587.76%1.32M
-358.82%-234K
438.24%134.56M
55.59%68.13M
118.81%43.13M
Net issuance payments of debt
--0
--0
--9.48M
----
----
--0
--0
--0
----
----
Net common stock issuance
--0
--0
--0
--137.58M
--0
--0
--0
--137.58M
--0
--0
Net preferred stock issuance
----
----
----
--0
--0
266.67%100K
--0
--0
104.31%70M
349.74%45.15M
Proceeds from stock option exercised by employees
128.36%153K
--0
1,880.00%198K
3.31%187K
68.97%49K
-38.53%67K
41.86%61K
--10K
--181K
--29K
Net other financing activities
--0
414.36%613K
81.98%-546K
-1.17%-2.08M
--0
--1.15M
---195K
---3.03M
-501.47%-2.05M
----
Cash from discontinued financing activities
Financing cash flow
-88.38%153K
361.97%613K
-93.22%9.13M
99.16%135.69M
-99.89%49K
2,587.76%1.32M
-358.82%-234K
438.24%134.56M
55.59%68.13M
118.81%43.13M
Net cash flow
Beginning cash position
-23.52%148.09M
-21.68%161.25M
104.40%168.73M
70.75%82.55M
255.25%182.2M
228.01%193.62M
213.01%205.9M
70.75%82.55M
88.07%48.34M
47.83%51.29M
Current changes in cash
14.45%-9.77M
-7.32%-13.17M
-106.04%-7.45M
151.93%86.19M
-143.12%-13.48M
-47.11%-11.41M
-82.02%-12.27M
606.69%123.35M
50.96%34.21M
129.33%31.26M
Effect of exchange rate changes
42.86%-4K
40.00%-3K
-340.00%-22K
-37.50%-11K
50.00%6K
-138.89%-7K
54.55%-5K
73.68%-5K
66.67%-8K
-80.00%4K
End cash Position
-24.09%138.32M
-23.52%148.09M
-21.68%161.25M
104.40%168.73M
104.40%168.73M
255.25%182.2M
228.01%193.62M
213.01%205.9M
70.75%82.55M
70.75%82.55M
Free cash flow
22.10%-9.92M
-14.50%-13.78M
-47.94%-16.58M
-45.94%-49.5M
-13.90%-13.53M
-63.05%-12.73M
-79.91%-12.03M
-48.54%-11.21M
-60.55%-33.92M
-95.23%-11.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.42%-9.92M-17.83%-13.78M-50.74%-16.56M-41.78%-47.42M-12.99%-13.02M-51.01%-11.73M-76.25%-11.69M-45.97%-10.98M-64.01%-33.45M-91.40%-11.52M
Net income from continuing operations 15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M-31.02%-36.31M-46.59%-11.22M
Operating gains losses 2,750.00%114K-94.44%1K197.12%722K-62.86%52K-93.74%30K101.77%4K117.65%18K2,309.09%243K-62.06%140K280.75%479K
Depreciation and amortization 34.43%164K49.56%169K76.29%171K34.58%502K51.79%170K93.65%122K0.89%113K12.79%97K9.06%373K15.46%112K
Other non cash items 239.46%499K-48.48%457K-0.48%411K1,066.89%1.76M190.52%315K-10.37%147K461.39%887K133.33%413K-42.59%151K-970.00%-348K
Change In working capital -53.45%1.3M-9.44%1.3M-1,727.06%-4.66M681.66%4.06M108.56%99K234.05%2.79M138.33%1.43M73.87%-255K-115.24%-698K-241.32%-1.16M
-Change in receivables ----------------------0--0121.62%8K--------
-Change in prepaid assets -15.59%628K310.48%509K5.00%-1.69M-259.11%-463K0.00%450K1,007.32%744K-67.96%124K-283.84%-1.78M593.22%291K259.01%450K
-Change in payables and accrued expense -67.24%669K-39.82%786K-294.43%-2.97M557.33%4.52M72.60%-351K228.82%2.04M794.52%1.31M421.26%1.53M-128.42%-989K-1,742.31%-1.28M
Cash from discontinued investing activities
Operating cash flow 15.42%-9.92M-17.83%-13.78M-50.74%-16.56M-41.78%-47.42M-12.99%-13.02M-51.01%-11.73M-76.25%-11.69M-45.97%-10.98M-64.01%-33.45M-91.40%-11.52M
Investing cash flow
Cash flow from continuing investing activities 0089.29%-24K-341.49%-2.08M-43.75%-506K-2,237.21%-1.01M-529.63%-340K-966.67%-224K35.79%-470K-467.74%-352K
Capital expenditure reported --0--089.29%-24K-341.49%-2.08M-43.75%-506K-2,237.21%-1.01M-529.63%-340K-966.67%-224K35.79%-470K-467.74%-352K
Cash from discontinued investing activities
Investing cash flow --0--089.29%-24K-341.49%-2.08M-43.75%-506K-2,237.21%-1.01M-529.63%-340K-966.67%-224K35.79%-470K-467.74%-352K
Financing cash flow
Cash flow from continuing financing activities -88.38%153K361.97%613K-93.22%9.13M99.16%135.69M-99.89%49K2,587.76%1.32M-358.82%-234K438.24%134.56M55.59%68.13M118.81%43.13M
Net issuance payments of debt --0--0--9.48M----------0--0--0--------
Net common stock issuance --0--0--0--137.58M--0--0--0--137.58M--0--0
Net preferred stock issuance --------------0--0266.67%100K--0--0104.31%70M349.74%45.15M
Proceeds from stock option exercised by employees 128.36%153K--01,880.00%198K3.31%187K68.97%49K-38.53%67K41.86%61K--10K--181K--29K
Net other financing activities --0414.36%613K81.98%-546K-1.17%-2.08M--0--1.15M---195K---3.03M-501.47%-2.05M----
Cash from discontinued financing activities
Financing cash flow -88.38%153K361.97%613K-93.22%9.13M99.16%135.69M-99.89%49K2,587.76%1.32M-358.82%-234K438.24%134.56M55.59%68.13M118.81%43.13M
Net cash flow
Beginning cash position -23.52%148.09M-21.68%161.25M104.40%168.73M70.75%82.55M255.25%182.2M228.01%193.62M213.01%205.9M70.75%82.55M88.07%48.34M47.83%51.29M
Current changes in cash 14.45%-9.77M-7.32%-13.17M-106.04%-7.45M151.93%86.19M-143.12%-13.48M-47.11%-11.41M-82.02%-12.27M606.69%123.35M50.96%34.21M129.33%31.26M
Effect of exchange rate changes 42.86%-4K40.00%-3K-340.00%-22K-37.50%-11K50.00%6K-138.89%-7K54.55%-5K73.68%-5K66.67%-8K-80.00%4K
End cash Position -24.09%138.32M-23.52%148.09M-21.68%161.25M104.40%168.73M104.40%168.73M255.25%182.2M228.01%193.62M213.01%205.9M70.75%82.55M70.75%82.55M
Free cash flow 22.10%-9.92M-14.50%-13.78M-47.94%-16.58M-45.94%-49.5M-13.90%-13.53M-63.05%-12.73M-79.91%-12.03M-48.54%-11.21M-60.55%-33.92M-95.23%-11.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -